Abstract

In our previous studies, expression of human interferon α-2b gene in Escherichia coli gave three types of polypeptide chains in nearly equimolar ratio. They include molecules with N-terminal methionine, molecules without N-terminal methionine, and molecules with acetylated N-terminal. This heterogeneity is not required in therapeutic applications. In order to improve the removal rate of N-terminus methionine, co-expression of human interferon α-2b and methionine aminopeptidase genes was performed in E. coli. The co-expression resulted in production of human interferon α-2b with dominance of molecules without N-terminal methionine and very few of them were acetylated at the N-terminus. Our findings contribute significantly to efforts for the production of homogenous therapeutic proteins which represent the exact recombinant replica of their native proteins.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.